1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study. - Weichenthal, M.; Schadendorf, D.; Bastholt, L.; Gavrilova, I.; Haanen, J.B.A.G.; Mangana, J.; Espinosa, E.; Svane, I-M.; Wouters, M.; Ellebæk, E.; Mohr, P.; Marques Rodas, I.; et al. (Annals of Oncology, 2023)